The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Optimal treatment for recurrent/metastatic head and neck cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726
Self-citationCisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Vermorken, J. B., Remenar, E., van Herpen, C., Gorlia, T., Mesia, R., Degardin, M., Stewart, J. S., Jelic, S., Betka, J., Preiss, J. H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071028 · Cited by 1,719
Self-citationCisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Forastiere, A., Koch, W., Trotti, A., & Sidransky, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmra001375 · Cited by 1,250
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R. L., Hammond, E. H., Fu, K. K., & Milas, L. (2002) · PubMed · Cited by 1,198
Vermorken, J. B., Trigo, J., Hitt, R., Koralewski, P., Diaz-Rubio, E., Rolland, F., Knecht, R., Amellal, N., Schueler, A., & Baselga, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7447 · Cited by 1,009
Self-citationRecent Advances in Head and Neck Cancer
Haddad, R. I., & Shin, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707975 · Cited by 916
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Burtness, B., Goldwasser, M. A., Flood, W., Mattar, B., & Forastiere, A. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4646 · Cited by 879
Soulieres, D., Senzer, N. N., Vokes, E. E., Hidalgo, M., Agarwala, S. S., & Siu, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.075 · Cited by 807
Forastiere, A. A., Metch, B., Schuller, D. E., Ensley, J. F., Hutchins, L. F., Triozzi, P., Kish, J. A., McClure, S., VonFeldt, E., & Williamson, S. K. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1245 · Cited by 752
Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
Marur, S., & Forastiere, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.489 · Cited by 739
Jacobs, C., Lyman, G., Velez-García, E., Sridhar, K. S., Knight, W., Hochster, H., Goodnough, L. T., Mortimer, J. E., Einhorn, L. H., & Schacter, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.257 · Cited by 628
Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cohen, E. E. W., Rosen, F., Stadler, W. M., Recant, W., Stenson, K., Huo, D., & Vokes, E. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.051 · Cited by 610
Chung, C. H., Ely, K., McGavran, L., Varella-Garcia, M., Parker, J., Parker, N., Jarrett, C., Carter, J., Murphy, B. A., Netterville, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2587 · Cited by 572
Gibson, M. K., Li, Y., Murphy, B., Hussain, M. H. A., DeConti, R. C., Ensley, J., & Forastiere, A. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.057 · Cited by 496
Baselga, J., Trigo, J. M., Bourhis, J., Tortochaux, J., Cortés-Funes, H., Hitt, R., Gascón, P., Amellal, N., Harstrick, A., & Eckardt, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.119 · Cited by 490
Profiling early head and neck cancer
Hunter, K. D., Parkinson, E. K., & Harrison, P. R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1549 · Cited by 437
Janot, F., de Raucourt, D., Benhamou, E., Ferron, C., Dolivet, G., Bensadoun, R.-J., Hamoir, M., Géry, B., Julieron, M., Castaing, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0102 · Cited by 405
Cancer: Principles and Practice of Oncology
Levi, J. A. (1987) · Pathology · doi:10.1016/s0031-3025(16)39749-5 · Cited by 404
Herbst, R. S., Arquette, M., Shin, D. M., Dicke, K., Vokes, E. E., Azarnia, N., Hong, W. K., & Kies, M. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.120 · Cited by 402
Stewart, J. S. W., Cohen, E. E. W., Licitra, L., Van Herpen, C. M. L., Khorprasert, C., Soulieres, D., Vodvarka, P., Rischin, D., Garin, A. M., Hirsch, F. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0530 · Cited by 382
Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)
Huang, S., Armstrong, E. A., Benavente, S., Chinnaiyan, P., & Harari, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0562 · Cited by 366
Xia, W., Lau, Y. K. J., Zhang, H. Z., Xiao, F. Y., Johnston, D. A., Liu, A. R., Li, L., Katz, R. L., & Hung, M. (1999) · PubMed · Cited by 327
Winer, E., Gralow, J., Diller, L., Karlan, B., Loehrer, P., Pierce, L., Demetri, G., Ganz, P., Kramer, B., Kris, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2134 · Cited by 293
Kimura, H., Sakai, K., Arao, T., Shimoyama, T., Tamura, T., & Nishio, K. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00510.x · Cited by 277
Matar, P., Rojo, F., Cassia, R., Moreno-Bueno, G., Di Cosimo, S., Tabernero, J., Guzmán, M., Rodriguez, S., Arribas, J., Palacios, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0870 · Cited by 277
Colevas, A. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3348 · Cited by 257
Santini, J., Formento, J., Francoual, M., Milano, G., Schneider, M., Dassonville, O., & Demard, F. (1991) · Head & Neck · doi:10.1002/hed.2880130209 · Cited by 254
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin
Ramakrishnan, M. S., Eswaraiah, A., Crombet, T., Piedra, P., Saurez, G., Iyer, H., & Arvind, A. S. (2009) · mAbs · doi:10.4161/mabs.1.1.7509 · Cited by 246
Cohen, E. E. W., Kane, M. A., List, M. A., Brockstein, B. E., Mehrotra, B., Huo, D., Mauer, A. M., Pierce, C., Dekker, A., & Vokes, E. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1247 · Cited by 233
Schneider-Merck, T., Lammerts van Bueren, J. J., Berger, S., Rossen, K., van Berkel, P. H. C., Derer, S., Beyer, T., Lohse, S., Bleeker, W. K., Peipp, M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900847 · Cited by 222
Chemotherapy in Head and Neck Cancer
Hong, W. K., & Bromer, R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301133080204 · Cited by 218
Bourhis, J., Rivera, F., Mesia, R., Awada, A., Geoffrois, L., Borel, C., Humblet, Y., Lopez-Pousa, A., Hitt, R., Vega Villegas, M. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3547 · Cited by 174
Siu, L. L., Soulières, D., Chen, E. X., Pond, G. R., Chin, S. F., Francis, P., Harvey, L., Klein, M., Zhang, W., Dancey, J. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.6547 · Cited by 152
Bleeker, W. K., van Bueren, J. J. L., van Ojik, H. H., Gerritsen, A. F., Pluyter, M., Houtkamp, M., Halk, E., Goldstein, J., Schuurman, J., van Dijk, M. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4699 · Cited by 152
Petrelli, N. J., Winer, E. P., Brahmer, J., Dubey, S., Smith, S., Thomas, C., Vahdat, L. T., Obel, J., Vogelzang, N., Markman, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6171 · Cited by 121 · cited 1×
“Cetuximab and platinum-based chemotherapy is now considered as a new standard for the treatment of R/M-SCCHN for those who are able to tolerate platinum-based combination chemotherapy regimens [7, 68].”
BackgroundHong, W. K., Schaefer, S. D., Issell, B. F., Cummings, C., Luedke, D., Bromer, R. H., Fofonoff, S. A., D'Aoust, J. C., Shapshay, S. M., Welch, J., et al. (1983) · Cancer · Cited by 121
Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A.-C., Ronchin, P., Schneider, M., Bleuze, J. P., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.019 · Cited by 119
Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
Kirby, A. M., A’Hern, R., D'Ambrosio, C., Tanay, M. A., Syrigos, K. N., Rogers, S. J., Box, C., Eccles, S. A., Nutting, C. M., & Harrington, K. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602999 · Cited by 97
de Andrés, L., Brunet, J., Pousa, A. L., Burgués, J., Vega, M., Tabernero, J. M., Mesía, R., & López, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1493 · Cited by 94
Schornagel, J. H., Verweij, J., de Mulder, P. H. M., Cognetti, F., Vermorken, J. B., Cappelaere, P., Armand, J., Wildiers, J., de Graeff, A., & Clavel, M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1649 · Cited by 78
Self-citationShin, D. M., Khuri, F. R., Glisson, B. S., Ginsberg, L. E., Papadimitrakopoulou, V., Clayman, G. L., Lee, J. J., Ang, K. K., Lippman, S. M., & Hong, W. K. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1316::aid-cncr1134>3.0.co;2-0 · Cited by 78
Panitumumab a novel drug in cancer treatment
Cartenì, G., Fiorentino, R., Vecchione, L., Chiurazzi, B., & Battista, C. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm218 · Cited by 36
Novel therapeutic targets in squamous cell carcinoma of the head and neck
Cohen, E. E. W. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.010 · Cited by 28
Targeted therapies in head and neck cancer
Specenier, P. M., & Vermorken, J. B. (2007) · Targeted Oncology · doi:10.1007/s11523-007-0048-3 · Cited by 21
Self-citationTopoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck
Murphy, B. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.1.85 · Cited by 21
Cited by
Activity‐Based NIR Enzyme Fluorescent Probes for the Diagnosis of Tumors and Image‐Guided Surgery
Li, H., Kim, D., Yao, Q., Ge, H., Chung, J., Fan, J., Wang, J., Peng, X., & Yoon, J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202009796 · Cited by 363
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
Siu, L. L., Even, C., Mesía, R., Remenar, E., Daste, A., Delord, J.-P., Krauss, J., Saba, N. F., Nabell, L., Ready, N. E., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4628 · Cited by 309
Luedke, E., Jaime-Ramirez, A. C., Bhave, N., Roda, J., Choudhary, M. M., Kumar, B., Teknos, T. N., & Carson, W. E. (2012) · Surgery · doi:10.1016/j.surg.2012.05.035 · Cited by 71
Mayland, C. R., Ingarfield, K., Rogers, S. N., Dey, P., Thomas, S., Waylen, A., Leary, S. D., Pring, M., Hurley, K., Waterboer, T., et al. (2020) · Palliative Medicine · doi:10.1177/0269216320904313 · Cited by 27
Metadata
- Authors
- Vermorken, J. B., & Specenier, P.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 21
- Pages
- vii252-vii261
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2118991777
- Cited by
- 383
- References
- 48
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.